August 6, 2015—Three and a half years after being released for public comment, the Medicaid covered outpatient drug rule, a.k.a. the AMP (average manufacturer price) final rule, could finally be nearing the finish line.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)